Doctor profile · Federal record
Dr. Uzoamaka Ogbonnah, MD
Pulmonary Disease Physician (CMS: Pulmonary Disease) · Critical Care Medicine (Internal Medicine) Physician · Critical Care Medicine (Internal Medicine) Physician · Student in an Organized Health Care Education/Training Program · Internal Medicine Physician · Tacoma, WA
- NPI 1528422508
- Accepts Medicare
- 10 yrs in practice
- Licensed in 3 states
- Female
- Group practice
- No sanctions
Practice & contact
Operates at 2 locations .
- Primary practice
-
1708 Yakima Ave Ste 300
Tacoma, WA 984055309
(253) 363-8700
fax (253) 272-0419 - Additional location
-
1 Atwell RD
Cooperstown, NY 133261394
(607) 547-3480
Credentials & registration
- NPI registered
- April 2016 — 10 yrs on file
- Profile last updated
- April 3, 2026
- Year of graduation
- 2016 — 10 yrs since
- Specialty taxonomy
- 207RP1001X — NUCC code
- State licenses (3)
- Washington #MD61274435 · New York #340655 · Louisiana #312440
- Medicaid
- WA #2211684
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1528422508. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
311
Distinct HCPCS
8
Medicare allowed
$33,971
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99291 |
Critical care, first 30-74 minutes | 106 | 54 | $205 | |
J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | 57 | 19 | $0 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 42 | 33 | $88 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 33 | 33 | $112 | |
94729 |
Test to examine how well the lungs exchange gases | 24 | 24 | $58 | |
94060 |
Test to measure expiratory airflow and volume changes before and after medication administration | 22 | 22 | $39 | |
99222 |
Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 14 | 14 | $131 | |
94726 |
Test to determine lung volumes using sensors | 13 | 13 | $55 |
In context: peer comparison
Among 12 peers in this city , average services per provider: 59. This provider delivers 5.3× the peer median.Open Payments
Industry payments received
All-time total
$63
Transactions
1
Manufacturers
1
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Inari Medical, Inc. | 1 | $62.51 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
197
Patients
13
Total drug cost
$80,463
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter) | Brand | 45 | 0 | $31,251 |
| Albuterol Sulfate Hfa (Albuterol Sulfate) | Brand | 39 | 13 | $1,084 |
| Advair Hfa (Fluticasone Propion/Salmeterol) | Brand | 29 | 0 | $13,903 |
| Spiriva Handihaler (Tiotropium Bromide) | Brand | 22 | 0 | $12,017 |
| Flovent Hfa (Fluticasone Propionate) | Brand | 15 | 0 | $4,465 |
| Anoro Ellipta (Umeclidinium Brm/Vilanterol Tr) | Brand | 12 | 0 | $5,930 |
| Prednisone | Generic | 12 | 0 | $83 |
| Spiriva Respimat (Tiotropium Bromide) | Brand | 12 | 0 | $6,271 |
| Symbicort (Budesonide/Formoterol Fumarate) | Brand | 11 | 0 | $5,459 |
Hospital affiliations
Frequently asked questions
What is Dr. Uzoamaka Ogbonnah's medical specialty?
Dr. Uzoamaka Ogbonnah practices Pulmonary Disease Physician in Tacoma, WA.
Where does Dr. Uzoamaka Ogbonnah practice?
Dr. Uzoamaka Ogbonnah practices at 1708 Yakima Ave Ste 300, Tacoma, WA 984055309. Office phone: 2533638700.
What is Dr. Uzoamaka Ogbonnah's NPI?
Dr. Uzoamaka Ogbonnah's National Provider Identifier (NPI) is 1528422508, issued by NPPES.
Does Dr. Uzoamaka Ogbonnah accept Medicare assignment?
Yes. Dr. Uzoamaka Ogbonnah accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Uzoamaka Ogbonnah commonly perform?
Top Medicare-reported procedures in 2023: Critical care (HCPCS 99291); Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg (HCPCS J7613); Established patient office or other outpatient visit (HCPCS 99213). Source: CMS Medicare Physician & Other Practitioners file.